Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice

Toxicology and Applied Pharmacology

Volumn 271, Issue 1, 2013, Pages 114-126

  Sun, Gui bo ^a   Qin, Meng ^a   Ye, Jing xue ^b   Pan, Rui le ^a   Meng, Xiang bao ^a   Wang, Min ^a   Luo, Yun ^a   Li, Zong yang ^a   Wang, Hong wei ^c   Sun, Xiao bo ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Atherosclerosis; Myricitrin; Oxidative stress

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; CASPASE 3; FLAVONOID; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYRICETIN 3 RHAMNOSIDE; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; TREATMENT DURATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; MYRICITRIN; OXIDATIVE STRESS;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BCL-2-ASSOCIATED X PROTEIN; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYRICA; NITRIC OXIDE; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES;

MORELLA CERIFERA; MUS; RATTUS;

EID: 84879323828     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.04.015     Document Type: Article

References (45)

1. Asano N., Kuno T., Hirose Y., Yamada Y., Yoshida K., Tomita H., Nakamura Y., Mori H. Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats. Asian Pac. J. Cancer Prev. 2007, 8:73-76.
2. Boatright K.M., Salvesen G.S. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 2003, 15:725-731.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Cargnello M., Roux P.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 2011, 75:50-83.
5. Chowdhury K.D., Sen G., Sarkar A., Biswas T. Role of endothelial dysfunction in modulating the plasma redox homeostasis in visceral leishmaniasis. Biochim. Biophys. Acta 2011, 1810:652-665.
6. Dali-Youcef N., Mecili M., Ricci R., Andres E. Metabolic inflammation: connecting obesity and insulin resistance. Ann. Med. 2012, 45:242-253.
7. del B.B.I., Nebreda A.R. Roles of p38 MAPKs in invasion and metastasis. Biochem. Soc. Trans. 2012, 40:79-84.
8. Dimmeler S., Zeiher A.M. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 2000, 87:434-439.
9. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68:383-424.
10. Fernandez S.P., Nguyen M., Yow T.T., Chu C., Johnston G.A., Hanrahan J.R., Chebib M. The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice. Neurochem. Res. 2009, 34:1867-1875.
11. Foongladda S., Roengsanthia D., Arjrattanakool W., Chuchottaworn C., Chaiprasert A., Franzblau S.G. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2002, 6:1118-1122.
12. Garczorz W., Francuz T., Gminski J., Likus W., Siemianowicz K., Jurczak T., Strzalka-Mrozik B. Influence of elastin-derived peptides, glucose, LDL and oxLDL on nitric oxide synthase expression in human umbilical artery endothelial cells. Acta Biochim. Pol. 2011, 58:375-379.
13. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003, 108:1912-1916.
14. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 2003, 108:2034-2040.
15. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993, 23(Suppl. 1):118-126.
16. Halliwell B., Clement M.V., Long L.H. Hydrogen peroxide in the human body. FEBS Lett. 2000, 486:10-13.
17. Han X., Pan J., Ren D., Cheng Y., Fan P., Lou H. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem. Toxicol. 2008, 46:3140-3146.
18. Han J., Shuvaev V.V., Muzykantov V.R. Targeted interception of signaling reactive oxygen species in the vascular endothelium. Ther. Deliv. 2012, 3:263-276.
19. Harauma A., Murayama T., Ikeyama K., Sano H., Arai H., Takano R., Kita T., Hara S., Kamei K., Yokode M. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochem. Biophys. Res. Commun. 2007, 358:751-756.
20. Harrison C.M., Pompilius M., Pinkerton K.E., Ballinger S.W. Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production. Environ. Health Perspect. 2011, 119:676-681.
21. Hernandez S., Lopez-Knowles E., Lloreta J., Kogevinas M., Jaramillo R., Amoros A., Tardon A., Garcia-Closas R., Serra C., Carrato A., Malats N., Real F.X. FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis. Clin. Cancer Res. 2005, 11:5444-5450.
22. Jo H., Song H., Mowbray A. Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis. Antioxid. Redox Signal. 2006, 8:1609-1619.
23. Kriszbacher I., Koppan M., Bodis J. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 353(429-430):429-430.
24. Lauzier B., Delemasure S., Collin B., Duvillard L., Menetrier F., Vergely C., Connat J.L., Rochette L. Effect of a chronic cholesterol-rich diet on vascular structure and oxidative stress in LDLR-/- mice. Cell. Physiol. Biochem. 2011, 27:31-36.
25. Lee R., Channon K.M., Antoniades C. Therapeutic strategies targeting endothelial function in humans: clinical implications. Curr. Vasc. Pharmacol. 2012, 10:77-93.
26. Li K., Chen X. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat. J. Mol. Cell. Cardiol. 1987, 19:909-915.
27. Liaudet L., Vassalli G., Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci. 2009, 14:4809-4814.
28. Maillet A., Pervaiz S. Redox regulation of p53, redox effectors regulated by p53: a subtle balance. Antioxid. Redox Signal. 2012, 16:1285-1294.
29. Meotti F.C., Posser T., Missau F.C., Pizzolatti M.G., Leal R.B., Santos A.R. Involvement of p38MAPK on the antinociceptive action of myricitrin in mice. Biochem. Pharmacol. 2007, 74:924-931.
30. Meotti F.C., Senthilmohan R., Harwood D.T., Missau F.C., Pizzolatti M.G., Kettle A.J. Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids. Free Radic. Biol. Med. 2008, 44:109-120.
31. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994, 14:133-140.
32. Nohl H., Kozlov A.V., Gille L., Staniek K. Cell respiration and formation of reactive oxygen species: facts and artefacts. Biochem. Soc. Trans. 2003, 31:1308-1311.
33. Oyama K., Takahashi K., Sakurai K. Cardiomyocyte H9c2 cells exhibit differential sensitivity to intracellular reactive oxygen species generation with regard to their hypertrophic vs death responses to exogenously added hydrogen peroxide. J. Clin. Biochem. Nutr. 2009, 45:361-369.
34. Peluso I., Morabito G., Urban L., Ioannone F., Serafini M. Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr. Metab. Immune Disord. Drug Targets 2012, 12:351-360.
35. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J. Biochem. Mol. Biol. 2003, 36:95-109.
36. Reed J.C. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 2006, 13:1378-1386.
37. Rees J.N., Florang V.R., Anderson D.G., Doorn J.A. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chem. Res. Toxicol. 2007, 20:1536-1542.
38. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
39. Ryter S.W., Kim H.P., Hoetzel A., Park J.W., Nakahira K., Wang X., Choi A.M. Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 2007, 9:49-89.
40. Sabapathy K. Role of the JNK pathway in human diseases. Prog. Mol. Biol. Transl. Sci. 2012, 106:145-169.
41. Sudoh N., Toba K., Akishita M., Ako J., Hashimoto M., Iijima K., Kim S., Liang Y.Q., Ohike Y., Watanabe T., Yamazaki I., Yoshizumi M., Eto M., Ouchi Y. Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 2001, 103:724-729.
42. Sun B., Sun G.B., Xiao J., Chen R.C., Wang X., Wu Y., Cao L., Yang Z.H., Sun X.B. Isorhamnetin inhibits H(2)O(2)-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J. Cell. Biochem. 2012, 113:473-485.
43. van der Valk F.M., van Wijk D.F., Stroes E.S. Novel anti-inflammatory strategies in atherosclerosis. Curr. Opin. Lipidol. 2012, 23:532-539.
44. Xi H., Akishita M., Nagai K., Yu W., Hasegawa H., Eto M., Kozaki K., Toba K. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis 2007, 191:281-289.
45. Xi Y.D., Yu H.L., Ding J., Ma W.W., Yuan L.H., Feng J.F., Xiao Y.X., Xiao R. Flavonoids protect cerebrovascular endothelial cells through Nrf2 and PI3K from beta-amyloid peptide-induced oxidative damage. Curr. Neurovasc. Res. 2012, 9:32-41.